Results 21 to 30 of about 15,859 (208)
Oligometastatic Prostate Cancer [PDF]
The mainstay of treatment for men with three or fewer non-castrate metastatic lesions outside of the prostate remains morbid palliative androgen deprivation therapy. We believe there is now a significant body of retrospective literature to suggest a survival benefit if these men have radical treatment to their primary tumour alongside 'metastasis ...
Stevens, Daniel J. +1 more
openaire +2 more sources
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
Oligometastatic prostate cancer (OMPC) has been proposed as an intermediary state between localised disease and widespread metastases, with varying definitions including 1, 3, or ≤5 visceral or bone metastasis.
Matthew Alberto +9 more
doaj +1 more source
Oligometastatic disease (OMD) is a stage between locally advanced disease and polymetastatic disease, a group of diseases that are used interchangeably based on treatment history, ongoing treatment status, and imaging findings. The diagnosis of OMD is based on imaging because, as of yet, we are not aware of any specific biomarkers that would enable us ...
Ivica Ratoša +12 more
openaire +2 more sources
Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms ...
Elena Verzoni +12 more
doaj +1 more source
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking.
Steven Borson +17 more
doaj +1 more source
Metastatic prostate cancer remains a challenge for clinicians. Metastases involve mainly the bone compartment and can manifest as oligometastatic disease.
Anne-Emmanuella Yeo +6 more
doaj +1 more source
Meta-analysis of prognosis of oligometastatic ...
petrelli, F (via Mendeley Data) +1 more
core +1 more source
Highlights on the Management of Oligometastatic Disease [PDF]
AbstractPurpose: The understanding of oligometastatic disease (OMD) is rapidly evolving and with this comes the ability to utilize a number of modalities that excel in the localized control of disease. It has been identified that there are no clear guidelines based on high-level evidence to standardized approaches toward the management of OMD.
Salem M. Alshehri +13 more
openaire +3 more sources
ObjectiveThe aim of this study was to investigate the efficacy and safety of combined applications of local consolidative radiation therapy (LCRT) and first-line tyrosine kinase inhibitors (TKIs) for the treatment of primary tumors and oligometastatic ...
Xiaolong Hu +7 more
doaj +1 more source
BackgroundThe continuous exploration of oligometastatic disease has led to the remarkable achievements of local consolidative therapy (LCT) and favorable outcomes for this disease.
Xiaolong Hu +12 more
doaj +1 more source

